|
|||||
|
|||||
|
Epidural fibrosis has been considered to be
enough of a concern to spine surgeons that its prevention has been a
subject of concern since the early 1900s when Lexer (Lexer
E: Die Freien Transplantation en Pat 1, Neue Deutsche Chirurgie
26:264-545, Stuttgart: Ferdinand Enke,1919) first
reported on the use of free fat grafts for this purpose. Many forms
of fat including pedicled grafts and a host of biocompatible materials
have continued to be tested. Mayfield, in 1980, documented his 16
years of clinical experience with fat grafts and noted that they could
prevent "constricting cicatrix" as well as serve to control
cerebro-spinal fluid leaks and in the repair of dural tears. He also
noted that their greatest danger was the possibility of their acting as a
space occupying lesion and causing neural compression (Mayfield
FH: Autologous Fat Transplants for the Protection and Repair of the Spinal
Dura, In Clinical Neurosurgery, Vol. 27, Baltimore: Williams and Wilkins,
1980) |
|||||
![]() ![]()
|
|||||
|
|
|||||
|
|||||
![]() |
|||||
The Burton Experience with routinely applied autogenous free fat grafts has extended over a 25 year period and has included approximately 5,000 cases. On the basis of this xperience the following observations are made: Indications for Use of Fat: Prevention of constricting epidural fibrosis Prevention of excessive epidural scar tissue. Preventing normal post-decompression dural dilatation. The prevention of cerebrospinal fluid leakage from dural tears and other defects. Filling dead space (i.e. arachnoidal cysts) Protective barrier (i.e. strut stabilization with milled bone). Advantages: Readily available material. Survives as normally vascularized fat. Allows for ease of dural separation in subsequent surgeries. Acts as additional protective barrier for dura. Is not neurotoxic to the subarachnoid space. Fat becomes vascularized and serves to nourish dura The price is right. Disadvantages: Can act as a space occupying mass and produce compression of neural elements. Consistency of fat is not uniform, areas of fat necrosis can occur. If separate incision is necessary hematoma formation is possible. Separate incisional donor site can be painful. Fat can act as a lubricant in subsequent surgeries and can increase the risk of instrument slippage. |
|||||
![]() |
|||||
|
Autogenous free fat grafts can be harvested from
the primary incisional site or through separate buttock incisions. Incisions should be made to avoid
interrupting the cluneal nerve
complex (see above). The quality of fat is important because thick and
fibrous adipose tissue is more likely to produce a mass effect. |
|||||
![]() |
This operative photograph shows a fat graft in-situ 6 years after a surgical procedure. Dorsal fat graft is identified by the yellow dot. The fat is normal and vascularized. The dural sac is shown at the site of the blue dot. The dural surface is essentially normal and was easily separated from the surrounding fat graft. Post-surgical dural dilatation has not occurred. Post-surgical dural compression producing cauda equina compression has occurred in less than 0.01% of the Editor's series. |
||||
| The cases
involved severe central spinal stenosis where the tension of the fat graft
impaired already abnormal roots of the cauda equina. In all cases
the patients immediate post-operative onset of sacral anesthesia and parasthesia associated with
leg weakness allowed early diagnosis, surgical revision, and subsequent
recovery. |
|||||
![]() |
|
||||
| MRI views of a 3 month post-operative patient
who had titanium cages inserted at the l3-4 level and local autologous fat
grafts. Slight post-operative dural sac dilatation is noted.
The fat has become vascularized and a pseudo-membrane is shown with the
green dots.
|
|||||
|
Alternative Substances In Preventing Epidural Fibrosis |
|||||
| Fat is not optimal, in all regards, as a
substance to be used in preventing
epidural fibrosis and serving as a barrier to excessive scar formation.
Fats greatest asset is that
it has withstood the test of time. Of the various natural and
artificial substances also being used as an alternative to fat grafts none
have yet been proven to be superior to
autogenous fat when all aspects are considered. |
|||||
| Adcon-L is a partially resorbable barrier gel substance composed of porcine derived gelatin and a complex sugar of the polyglycan family in a phosphate buffered saline solution. | |||||
| Manufactured
by Gliatech (www.gliatech.com) this product was
approved by the United States Food and Drug Administration in May 1998 . The
Adcon-L gel represents the beginning of
important new technology in addressing the control of unwanted
post-operative adhesions. Its major benefit is that it does not
appear to act as a space-occupying lesion or an irritant. It's major liability is that it does
not act as a space occupying mass to exert a desired tension on surrounding
spinal tissues and gain this advantage. The
use of Adcon-L adds about $800-1,000 to the patient's hospital bill.
Despite shortcomings there continues to remain significant commercial interest in developing various
substances intended to reduce post-operative adhesions. As of the year 2000 the Burton Report®
has
identified the following organizations involved in developing such
products:
|
|||||
|
|||||
At the present time the careful use of autogenous fat grafts of proper volume and consistency
represent the procedure of choice in the majority of spine surgery cases to avoid
undesired epidural fibrosis. The only reason that free fat grafts
are not used more widely appears to have to do with lack of understanding
of "Pitfall Prevention">
|
|||||